Biotech | October 14, 2021
Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic
UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste
The amalgamation is expected to bring in a lot of synergies in terms of operational efficiency and productivity for the combined entity
Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month
Invega Hafyera offers patients the fewest doses per year. Phase 3 non-inferiority study results showed over 92% of participants were relapse-free at 12 months
JADE DARE trial met co-primary and key secondary endpoints and demonstrated a safety profile consistent with previous studies for moderate to severe atopic dermatitis
Results reinforce the well-established safety profile of Dupixent - the first-ever biologic medicine for atopic dermatitis currently approved for patients as young 6 years old
It is estimated that over 11,000 children across Europe, Middle East, and Africa are affected by achondroplasia and could be eligible for treatment with Voxzogo
Subscribe To Our Newsletter & Stay Updated
